A variety of inhibitory pathways are known to play a role in the tumor microenvironment, including cells such as Th2 macrophages and immature T regulatory cells (Tregs), and molecules such as checkpoints that control T cell differentiation (such as CTLA-4 and IDO) and effector function (such as PD-1). Here, IDO1 is linked to neoplasm.